ABK Biomedical

About ABK Biomedical

ABK Biomedical Inc. is a medical technology startup focused on improving treatment options for patients with hypervascular tumors, which are tumors with an excessive number of blood vessels. The company operates in the healthcare sector, specifically within the niche of interventional radiology, a medical specialty that uses imaging techniques to guide minimally invasive surgical procedures.

ABK Biomedical's flagship product is Eye90, a groundbreaking combination of Yttrium-90 (Y-90) for radioembolization—a treatment that uses radioactive particles to target and destroy cancer cells—and a radiopaque glass composition. This unique combination allows for unprecedented procedural visualization, meaning doctors can see the treatment in real-time, enhancing precision and effectiveness.

The company primarily serves hospitals and medical professionals who specialize in treating cancer patients. By providing advanced tools for radioembolization, ABK Biomedical aims to improve patient outcomes and offer more effective treatment options.

ABK Biomedical operates on a business-to-business (B2B) model, selling its medical devices directly to healthcare providers. The company generates revenue through the sale of its Eye90 product and potentially through future products currently in development.

Recently, ABK Biomedical raised $30 million in Series B financing, which will likely be used to further develop its technology and expand its market reach. The company has also formed strategic partnerships with the University of Missouri Research Reactor Center and the Canadian Nuclear Isotope Council, which will help in the advancement and distribution of their innovative treatments.

Leadership at ABK Biomedical includes Michael J. Mangano as President and CEO, Mike Tyson as Chief Financial Officer, and Gary Donofrio as Chief Commercial Officer, among others. This diverse team brings together expertise from science, engineering, medicine, and business, making the company well-rounded and capable of tackling complex challenges in the medical field.